ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 780

$586K Total Retail Price of All Prescriptions

Rank: 239 out of 780

593 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 11,625 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 697 563 1 2
AMLODIPINE BESYLATE 657 553 2 4
LISINOPRIL 654 477 3 6
LEVOTHYROXINE SODIUM 584 466 4 5
METFORMIN HCL 486 343 5 8
OMEPRAZOLE 422 296 6 3
BISOPROLOL-HYDROCHLOROTHIAZIDE 378 312 7 95
FUROSEMIDE 376 278 8 7
POTASSIUM CHLORIDE 355 298 9 11
TRAMADOL HCL 345 252 10 15
MELOXICAM 316 280 11 16
HYDROCHLOROTHIAZIDE 278 229 12 10
HYDROCODONE-ACETAMINOPHEN 249 198 S3 13 1
CITALOPRAM HBR 248 187 14 23
ATENOLOL 221 167 15 21
PRAVASTATIN SODIUM 220 183 16 9
GLIMEPIRIDE 217 180 17 30
METOPROLOL SUCCINATE 199 172 18 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 188 177 19 26
TRIAMTERENE-HCTZ 186 168 20 37
LOSARTAN POTASSIUM 174 157 21 18
ATORVASTATIN CALCIUM 174 153 21 12
METOPROLOL TARTRATE 169 143 23 19
BISOPROLOL FUMARATE 161 143 24 143
GABAPENTIN 148 105 25 13
NIFEDIPINE ER 138 115 26 115
WARFARIN SODIUM 132 115 27 24
ZOLPIDEM TARTRATE 124 95 28 17
SPIRONOLACTONE 122 95 29 53
FLUTICASONE PROPIONATE 119 80 30 41
BENAZEPRIL HCL 114 92 31 59
TAMSULOSIN HCL 113 107 32 36
CLOPIDOGREL 111 108 33 34
NEXIUM 108 61 34 22
ETODOLAC 107 92 35 174
ALLOPURINOL 101 84 36 29
CRESTOR 89 72 37 32
MECLIZINE HCL 83 60 38 83
FAMOTIDINE 81 75 39 86
SINGULAIR 80 48 40 73
PANTOPRAZOLE SODIUM 78 66 41 25
MIRTAZAPINE 77 40 42 58
PLAVIX 77 75 42 45
AMITRIPTYLINE HCL 71 36 R 44 48
PREDNISONE 70 59 45 40
NIFEDIAC CC 69 49 46 402
AZITHROMYCIN 67 44 47 38
TRICOR 65 44 48 152
LABETALOL HCL 65 65 48 159
CARVEDILOL 64 62 50 14
AMLODIPINE BESYLATE-BENAZEPRIL 63 56 51 50
FOSINOPRIL SODIUM 63 51 51 112
LEVOFLOXACIN 62 47 53 76
JANUVIA 60 50 54 85
SERTRALINE HCL 58 38 55 27
CIPROFLOXACIN HCL 56 51 56 49
KLOR-CON M20 56 47 56 57
ALENDRONATE SODIUM 54 53 58 44
FLUOXETINE HCL 53 18 59 65
ISOSORBIDE MONONITRATE ER 52 52 60 60
AMIODARONE HCL 52 52 60 139
LANTUS 52 52 60 71
ADVAIR DISKUS 51 42 63 68
CYMBALTA 51 26 63 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.